title: Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma.
authors.forename: M
authors.initials: M
authors.lastname: Hus
authors.forename: A
authors.initials: A
authors.lastname: Dmoszyńska
authors.forename: J
authors.initials: J
authors.lastname: Kocki
authors.forename: I
authors.initials: I
authors.lastname: Hus
authors.forename: D
authors.initials: D
authors.lastname: Jawniak
authors.forename: M
authors.initials: M
authors.lastname: Adamczyk-Cioch
authors.forename: N
authors.initials: N
authors.lastname: Grzasko
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D000368:Aged; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D012333:RNA, Messenger / Q000032:analysis / Q000187:drug effects; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D012333:RNA, Messenger; D013792:Thalidomide